retatrutide 2.5 mg 10mg/20mg/30mg/60mg RETATRUTIDE + CAGRILINTIDE – Research
Description
Recent research has shown that berberine and its derivatives can enhance GLP-1 secretion from intestinal cells the same hormone targeted by popular prescription weight loss medications
This is where a specialized compounding pharmacy provides an indispensable advantage
Natural GLP-1 supplements are generally well-tolerated
Retatrutide is completing its Phase 3 TRIUMPH clinical program, with seven additional Phase 3 readouts expected through 2026
Although the effectiveness of current GLP-1 agonists has been demonstrated, there are some side-effects associated with their use gastrointestinal issues such as nausea, vomiting, and mental health changes like anxiety and irritability, she notes
